Trust Route2Health for your health and wellness needs
Considering Tirzepatide Newer dual-agonist (GLP-1 + GIP)
The global phase III clinical trial program Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) showed that the glucose-lowering effect of once-weekly semaglutide was significantly better than that of all the other comparators, and it had multiple cardiovascular and metabolic benefits, such as improving blood pressure, blood lipids, and body weight control [8,9,10,11,12,13,14,15,16]
Clinicians also caution that dosing strategies are not interchangeable across formulations or strengths, and inappropriate dose adjustments can result in clinically meaningful errors
Jun 13th, 2022 Leptin Resistance The Basics in Weight Loss When it comes to both gaining and losing weight, there are more factors at play than nutrition, exercise and willpower
Increased water volume